Englander Institute for Precision Medicine

OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity.

TitleOCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity.
Publication TypeJournal Article
Year of Publication2021
AuthorsDoane AS, Chu C-S, Di Giammartino DCampigli, Rivas MA, Hellmuth JC, Jiang Y, Yusufova N, Alonso A, Roeder RG, Apostolou E, Melnick AM, Elemento O
JournalNat Immunol
Volume22
Issue10
Pagination1327-1340
Date Published2021 Oct
ISSN1529-2916
KeywordsAnimals, B-Lymphocytes, Cell Differentiation, Chromatin, Epigenomics, Female, Genomics, Germinal Center, Immunity, Humoral, Male, Mice, Mice, Inbred C57BL, Organic Cation Transporter 2, Protein Domains, Transcription Factors
Abstract

During the germinal center (GC) reaction, B cells undergo profound transcriptional, epigenetic and genomic architectural changes. How such changes are established remains unknown. Mapping chromatin accessibility during the humoral immune response, we show that OCT2 was the dominant transcription factor linked to differential accessibility of GC regulatory elements. Silent chromatin regions destined to become GC-specific super-enhancers (SEs) contained pre-positioned OCT2-binding sites in naive B cells (NBs). These preloaded SE 'seeds' featured spatial clustering of regulatory elements enriched in OCT2 DNA-binding motifs that became heavily loaded with OCT2 and its GC-specific coactivator OCAB in GC B cells (GCBs). SEs with high abundance of pre-positioned OCT2 binding preferentially formed long-range chromatin contacts in GCs, to support expression of GC-specifying factors. Gain in accessibility and architectural interactivity of these regions were dependent on recruitment of OCAB. Pre-positioning key regulators at SEs may represent a broadly used strategy for facilitating rapid cell fate transitions.

DOI10.1038/s41590-021-01025-w
Alternate JournalNat Immunol
PubMed ID34556886
PubMed Central IDPMC9829245
Grant ListR01 CA178765 / CA / NCI NIH HHS / United States
R01 AI148387 / AI / NIAID NIH HHS / United States
R01 CA194547 / CA / NCI NIH HHS / United States
F31 CA220981 / CA / NCI NIH HHS / United States
UL1 TR002384 / TR / NCATS NIH HHS / United States
R35 CA220499 / CA / NCI NIH HHS / United States
P01 CA229086 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021